Iterum extends $20M Pfizer milestone payment to Oct 2029; interest rises to 10%

Iterum Therapeutics plc

$20M regulatory milestone due Oct 2026 extended to Oct 2029 via amended promissory note.
Interest rate increases from 8% to 10%, compounded daily, starting Oct 26, 2026.
ITIL pays Pfizer a transaction fee plus legal expenses; no senior debt or liens without Pfizer consent.
CEO says extension allows capital to be invested in ORLYNVAH launch and geographic expansion.

item 1.01 item 2.03 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000950170-25-073950
form_type: 8-K
ticker: ITRMF
cik: 0001659323
company_name: Iterum Therapeutics plc
filed_at: 2025-05-19T23:59:59+00:00
discovered_at: 2026-05-14T18:02:49.236998+00:00
generated_at: 2026-05-21T01:47:50.560864+00:00
sec_items: ["1.01", "2.03", "7.01", "9.01"]
event_type: debt
sentiment: positive
materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000950170-25-073950
json_url: https://secwatch.observer/filing/0000950170-25-073950.json
markdown_url: https://secwatch.observer/filing/0000950170-25-073950.md
text_url: https://secwatch.observer/filing/0000950170-25-073950.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1659323/000095017025073950/0000950170-25-073950-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1659323/000095017025073950/itrm-20250513.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0000950170-25-073950

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.